Unusually large von Willebrand factor multimers might be involved in cardiovascular events in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect the severity of apnoeic episodes Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Changes of plasma von Willebrand factor in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007
Diagnostic value of Von Willebrand factor (VWF) in patients suffering from respiratory distress Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011
Microalbuminuria and von Willebrand factor antigen (vWF) as markers of endothelial dysfunction in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 123s Year: 2004
Expression of CD 34 and von Willebrand factor in pulmonary endothelium Source: Eur Respir J 2001; 18: Suppl. 33, 243s Year: 2001
Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020
Endothelial injury in COPD assessed by microalbuminuria (MAB) and von Willebrand factor levels (vWf:Ag) and activity (vWf:Ac) Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004
Endotrophin and von Willebrand factor processing as predictive markers for mortality in the ECLIPSE COPD cohort Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Response of plasma von Willebrand factor to systemic endothelial injury in pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 545s Year: 2006
Plasma levels of vascular endothelial growth factor in children with sleep-disordered breathing Source: Annual Congress 2005 - Sleep apnoea in children Year: 2005
The role of complement factor H and clusterin in obstructive sleep apnoea Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020
Platelet function in patients with obstructive sleep apnea syndrome characterized by means of membrane bound P-selectin expression Source: Eur Respir J 2002; 20: Suppl. 38, 214s Year: 2002
PP308 – Endothelial injury in Chronic Obstructive Pulmonary Disease assessed by microalbuminuria (MAB) and von Willebrand factor levels and activity Source: ERS Lung Science Conference 2021 Year: 2021
Is obstructive sleep apnoea a risk factor for cardiovascular disease? Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy Year: 2005
Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009
Sleep apnoea syndrome, a causative factor of nocturnal microalbuminuria Source: Eur Respir J 2003; 22: Suppl. 45, 90s Year: 2003
Vascular endothelial growth factor in sleep apnea syndrome and chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005
BNP or VEGF levels do not predict disease severity in obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005